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Allelic variation at the melanocyte stimulating hormone
receptor (MC1R) gene has been linked with sun-sensitive
skin types, suggesting it is a susceptibility candidate
for melanoma. We determined the frequency of the
val92met, asp294his, and asp84glu MC1R alleles in 190
Caucasian controls and 306 melanoma cases and studied
their association with skin type and hair color. The
percentage of controls with at least one val92met,
asp294his, or asp84glu allele was 17.3%, 6.8%, and 3.5%,
respectively. Individually, frequencies of the val92met,
asp294his, or asp84glu alleles in the controls with skin
types 3 and 4 were similar to those with skin types 1 and
2. Trend analysis, however, did identify an association
(exact p J 0.048, two-sided test) between skin type and
MC1R variants in the group comprising all controls with
any one or more of these alleles. There was no association
between MC1R alleles and hair color. Allele frequencies
were not different in melanoma cases and controls.
There were no associations between skin types and the
Melanoma is a major health problem especially inCaucasians. Lifetime risk is estimated to be 0.5–1.0% and incidence rates are increasing (Armstrongand Kricker, 1994; Boyle et al, 1995; Rivers, 1996).Exposure to ultraviolet radiation (UV) is critical
although the relationship between risk and exposure is not a simple
cumulative one (Rivers, 1996). Thus, melanoma are often found on
skin that receives less UV (e.g., trunk in men) and in individuals who
are not continuously exposed (Weinstock, 1996). The relationship
between exposure and melanoma may also differ with histologic type.
In Caucasians, superficial spreading, lentigo maligna, and nodular
melanomas are most common (Boyle et al, 1995). Whereas it is not
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proportion of cases with the asp294his or asp84glu alleles,
though the association between skin type and the val92-
met allele approached significance (exact p J 0.09, two-
sided test). Unexpectedly, in the group comprising all
cases with one or more variant alleles, the proportion of
subjects with variant alleles increased with skin types
associated with tanning rather than burning, although
trend analysis showed that this association did not quite
reach statistical significance (exact p J 0.08, two-sided
test). Asp84glu (but not val92met or asp294his) variant
alleles were more common in subjects with blonde hair,
although the relationship between the asp84glu allele
and hair color did not achieve statistical significance
(χ23 J 6.16, exact p J 0.10). We interpret the data
presented as indicating that polymorphism at MC1R does
not appear a major determinant of skin type, at least in
terms of these allelic variants. Furthermore, considered
alone, these alleles are not susceptibility candidates for
malignant melanoma. Key words: genetic predisposition/
ultraviolet light. J Invest Dermatol 111:218–221, 1998
clear that these represent different diseases, nodular lesions are thicker
and associated with worse prognosis than other types (Barnhill et al,
1996) and lentigo maligna is generally found in elderly Caucasians.
Various host factors related to response to UV determine melanoma
risk; blue compared with brown eyes, fair or red compared with brown
or black hair, and skin that always burns and never tans on exposure
to UV (compared with less sun-sensitive skin) (Katsambas and
Nicolaidou, 1996).
Tanning represents the production of new melanin. There are two
types of melanin in human skin; eumelanin, which is photoprotective,
and phaeomelanin, which may contribute to cancer risk because it
generates free radicals following UV exposure. The relative proportion
of eumelanin and phaeomelanin in mammals is regulated by the
extension locus that encodes the melanocyte stimulating hormone
receptor (MC1R) (Suzuki et al, 1996; Koppula et al, 1997). The
protein product of this gene includes seven transmembrane domains.
Recently, polymorphism has been identified in the MC1R gene; eight
alleles result from changes in residues that lie in a 42 amino acid region
spanning the second transmembrane domain. A ninth allele results
from an altered residue in the seventh transmembrane domain (Valverde
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et al, 1995; Koppula et al, 1997). The functional significance of all of
these alleles is not yet known, although the val92met allele confers
reduced MSH affinity allowing relatively increased synthesis of phaeo-
melanin (Xu et al, 1996). Significantly, MC1R alleles have been linked
with sun-sensitive skin types (Valverde et al, 1995); mutations were
found in over 75% of individuals with skin type 1, 55% with skin type
2, but less than 5% of individuals with skin types 3 and 4. Mutations
were also found in 82% of subjects with red hair but in only 11.5% of
those with black hair. Accordingly, it has been proposed that the
MC1R gene is a susceptibility candidate for melanoma (Rees and
Healy, 1997), a view supported by studies in 43 cases and 44 controls
showing an increased frequency of mutant alleles in melanoma cases
(Valverde et al, 1996).
We now describe a case control study to assess the importance of
the MC1R polymorphism in determining melanoma risk. We have
studied the val92met and asp294his alleles as Valverde et al (1995)
suggest that they are found in about 90% of individuals with variant
alleles. We also examined the asp84glu variant as Valverde et al (1996)
only found this allele in melanoma cases and proposed that it is associated
with melanoma development. First, we describe the association between
alleles, skin type, and hair color in 190 Caucasian controls, and second,
we describe a comparison of genotype frequencies and skin type in
controls and 306 melanoma cases. Within the cases we also examined
the data for associations between MC1R alleles and tumor type and site.
MATERIALS AND METHODS
Patients Three hundred and six unrelated, Northern European Caucasian
patients with histologically confirmed melanoma of the skin were recruited
between January 1994 and December 1997, from Dermatology clinics in
the North Staffordshire Hospital, Stafford General Hospital, Leicester Royal
Infirmary, and Royal Cornwall Hospitals. Patients with other malignancies
(cutaneous or internal) were excluded. The mean age of this case group (64%
women) was 53.0 6 16.6 y. They were classified by tumor site (head and neck,
trunk, upper limbs, and lower limbs) and type (in situ, lentigo, nodular,
superficial spreading) (Table I). As expected (Katsambas and Nicolaidou, 1996),
the mean age at diagnosis of patients with lentigo maligna (66.9 6 12.2 y) was
older than in those with nodular (56.3 6 15.6 y), superficial spreading
(48.0 6 16.0 y), or in situ (48.5 6 15.3 y) melanoma. Further, lentigo maligna
lesions were more commonly found on chronically exposed sites (head and
neck; 60% of lesions) compared with other melanoma types (6–15% of lesions).
The controls (52% women) comprised 190 unrelated, Northern European
Caucasians with a basal cell papilloma but without clinical or histologic evidence
of any malignancy. Their mean age was 58.8 6 18.0 y. Cases and controls
were interviewed by a dermatologist (JTL, AS, AHMH, BB, PH, JO), familiar
with the study aims, to obtain where possible, information on skin type
(Fitzpatrick, 1988) and hair color at 21 y of age. Inevitably, not all clinical data
were obtained from patients recruited into the study due to insufficient time
in busy out-patient clinics. None of those approached refused to participate.
Identification of MSH receptor alleles DNA was extracted from
peripheral blood (5 ml; collected into ethylenediamine tetraacetic acid) using
standard phenol-chloroform methods. Samples were obtained with Ethical
Committee approval and informed consent. Polymerase chain reaction (PCR)-
restriction fragment length polymorphism-based assays were used to identify
alleles containing the val92met, asp294his, and asp84glu variants. Primers were
selected based on the MC1R gene sequence described by Chhajlani and
Wikberg (1992). The val92met and asp84glu alleles were identified using
primers 59-ATGGAGCTGCAGGTGATCAC-39 and 59-ATGGCTGTGCA-
GGGATCCCA-39 to amplify a 383 bp product. The PCR conditions were
95°C for 2 min, followed by 35 cycles of 95°C (45 s), 58°C (1 min), 72°C
(45 s), followed by 72°C for 5 min. The val92met allele was identified by
digestion with NlaIII (37°C, 20 h) and the products were examined after
electrophoresis in 4% agarose gels. Wild-type homozygotes (val/val) were
identified by fragments of 219 and 164 bp and homozygotes for the mutant
allele (met/met) by fragments of 219, 107, and 57 bp (Fig 1a). The asp84glu
allele was identified by digestion with AvaII (37°C, 20 h) and the products
were examined in 2% agarose gels. Wild-type homozygotes (asp/asp) were
identified by fragments of 249 and 134 bp and homozygotes for the mutant
allele (glu/glu) by a fragment of 383 bp (Fig 1b). The asp294his allele
was identified using primers 59-CTGCATCTCACACTCATCGT-39 and 59-
GCACACTTAAAGCGCGTGCA-39. The PCR conditions were 95°C for
2 min, followed by 35 cycles of 95°C (45 s), 55°C (1 min), 72°C (45 s),
followed by 72°C for 5 min. The 205 bp PCR product from the wild-type
homozygotes (asp/asp) was digested with Taq1 (37°C, 20 h) to give predicted
fragments of 106 and 99 bp in polyacrylamide gels, but were indistinguishable
after electrophoresis in 2% agarose gels (Fig 1c). Homozygotes for the mutant
allele (his/his) was not digested (205 bp product) and heterozygotes were
identified by DNA fragments of 205, 106, and 99 bp (Fig 1c).
Statistical analysis Chi-squared tests were used to test for homogeneity
between and within cases and controls (Altman, 1991). As some frequencies
were small, the StatXact-Turbo statistical package was used to obtain exact p
values. The Armitage Trend test was used to examine the relationship between
MC1R alleles and skin types 1–4 (Altman, 1991). This test is used to identify
an increase or decrease in proportions over ordered categories (such as skin
type), as distinct from the chi-squared test that is used to determine if categories
differ in proportions. Though it would be expected that trends would be
decreasing with respect to skin type (and therefore a one-sided test used), our
data show that this may not be the case. We have therefore used two-sided
tests throughout. Logistic regression analysis was used to examine differences
between cases and controls while simultaneously correcting for imbalances in
age, gender, and skin type.
RESULTS
MC1R alleles in the controls Table I shows the numbers of
controls with at least one copy of the val92met, asp294his, or asp84glu
alleles. Thus, due to the rarity of homozygosity for variant alleles,
homozygotes and heterozygotes for a particular allele were combined.
In controls, we identified three val92met homozygotes (but no
homozygotes for the asp294his or asp84glu alleles) and one val92met/
asp84glu compound heterozygote. Frequencies for the val92met,
asp294his, and asp84glu alleles were 0.095, 0.034, and 0.017, respect-
ively, and 26.4% of the controls demonstrated one or more of these
three alleles.
Table I also shows the numbers of controls with these alleles
grouped by skin type. We found no significant differences in the
proportion of controls with one or more copies of the val92met,
asp294his, or asp84glu alleles in the subjects with skin types 3 and 4
compared with those with skin types 1 and 2. Analysis of the data
using the Armitage trend test also did not identify significant increases
or decreases in the proportion of patients with at least one copy of
these alleles and skin type. The trend test did, however, identify a
significant association (exact p 5 0.048, two-sided test) between skin
type and MC1R variants in the group comprising all the controls with
any one or more of the three variant alleles.
No significant associations were identified between the presence of
one or more of the three MC1R alleles and red, blonde, brown, or
black hair. None the less, the frequency of variant alleles was not
greater in controls with red and/or those with blonde compared with
those with brown hair (Table I).
MC1R alleles in the melanoma cases Table I shows the propor-
tions of melanoma patients demonstrating one or more of the MC1R
allelic variants. We identified two asp294his homozygotes (but no
homozygotes for the val92met or asp84glu alleles). One of these
patients was also positive for the asp84glu variant, indicating one allele
contained two separate mutations (a phenomenon also described by
Valverde et al, 1995). Seven compound heterozygotes were identified;
these comprised four cases with val92met/asp84glu, two with val92met/
asp294his, and one with asp294his/asp84glu genotypes (this latter
patient was the patient described above who was homozygous for the
asp294his allele).
Table I shows the frequency of MC1R variants in melanoma cases
with skin types 1–4. There were no significant associations between
skin type and the proportion of subjects with the asp294his or asp84glu
alleles, though the Armitage trend test showed the association between
skin type and the proportion of cases with a copy of the val92met allele
approached significance (p 5 0.09). Similarly, in the group that
included all the cases with one or more variant alleles, the proportion
of subjects with variant alleles increased with skin types associated with
tanning rather than burning, though trend analysis showed that this
association did not quite reach statistical significance (exact p 5 0.08)
using a two-sided test.
The association between MC1R variant alleles and hair color is
shown in Table I. Only three of 14 melanoma cases with red hair
were found to have a variant allele, whereas 10 of 34 cases with blonde
hair demonstrated such variants. In the cases with brown and black
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Table I. Numbers of homo- and heterozygotes for MC1R alleles in controls and melanoma casesa
Val92met Asp294his Asp84glu Combined
positive positive positive
Controls
Total group 31/179 (17.3%) 13/190 (6.8%) 6/168 (3.5%) 44/167 (26.4%)
Skin type
1 2/17 (11.8%) 1/19 (5.3%) 0/18 (0.0%) 3/16 (18.8%)
2 10/43 (23.3%) 4/45 (8.9%) 2/43 (4.7%) 15/39 (38.5%)
3 8/49 (16.3%) 1/51 (2.0%) 2/49 (4.1%) 9/48 (18.8%)
4 2/24 (8.3%) 0/23 (0.0%) 0/22 (0.0%) 1/22 (4.6%)
Hair color
red 0/10 (0.0%) 2/11 (18.2%) 0/10 (0.0%) 2/9 (22.2%)
blonde 1/15 (6.7%) 0/17 (0.0%) 1/17 (5.9%) 2/14 (14.3%)
brown 14/57 (24.6%) 4/60 (6.7%) 2/56 (3.6%) 16/54 (29.6%)
black 0/5 (0.0%) 0/4 (0.0%) 0/5 (0.0%) 0/4 (0.0%)
Melanoma
Total group 54/287 (18.8%) 22/306 (7.2%) 20/299 (6.7%) 84/275 (30.6%)
Skin type
1 6/43 (14.0%) 5/45 (11.1%) 1/45 (2.2%) 11/43 (25.6%)
2 22/134 (16.4%) 10/149 (6.7%) 9/148 (6.1%) 36/130 (27.2%)
3 11/47 (23.4%) 4/52 (7.7%) 4/49 (8.2%) 16/45 (35.6%)
4 4/12 (33.3%) 0/12 (0.0%) 2/11 (18.2%) 6/11 (54.5%)
Hair color
red 0/14 (0.0%) 3/14 (21.4%) 0/14 (0.0%) 3/14 (21.4%)
blonde 5/34 (14.7%) 1/37 (2.7%) 5/37 (13.5%) 10/34 (29.4%)
brown 23/99 (23.2%) 6/117 (5.1%) 5/115 (4.4%) 31/95 (32.6%)
black 3/12 (25.0%) 1/12 (8.3%) 0/11 (0.0%) 4/11 (36.4%)
Tumor type
in situ 8/36 (22.2%) 3/41 (7.3%) 1/40 (2.5%) 12/35 (34.3%)
lentigo 3/23 (13.0%) 0/21 (0.0%) 2/20 (10.0%) 3/20 (15.0%)
nodular 7/30 (23.3%) 4/35 (11.4%) 1/34 (2.9%) 11/29 (37.9%)
superficial spreading 21/114 (18.4%) 8/125 (6.4%) 8/124 (6.5%) 36/112 (32.1%)
Tumor site
head/neck 4/26 (15.4%) 1/28 (3.6%) 3/26 (11.5%) 5/23 (21.7%)
trunk 11/75 (14.7%) 6/82 (7.3%) 7/81 (8.6%) 22/73 (30.1%)
upper limb 10/36 (27.8%) 6/41 (14.6%) 2/39 (5.1%) 16/34 (47.1%)
lower limb 14/88 (15.9%) 6/95 (6.3%) 6/95 (6.3%) 23/87 (26.4%)
aCompound heterozygotes will appear in more than one column under the analysis of individual alleles, but only once in the combined column. Thus, the ‘‘combined’’ column does
not necessarily represent the sum of values for the individual alleles.
Figure 1. PCR identification of MC1R alleles. (a) Val92met (left to right):
negative control (no DNA), homozygous wild-type, heterozygote, homozygous
mutant, molecular weight markers (pBr322 HindIII digest); (b) asp84glu (left
to right): negative control (no DNA), homozygous wild-type, heterozygote,
homozygous mutant, molecular weight markers; (c) asp294his (left to right):
negative control (no DNA), homozygous wild-type, heterozygote, homozygous
mutant, molecular weight markers.
hair, the proportion of individuals with variant alleles was 32.6% and
36.4%, respectively, demonstrating that variant alleles were not more
common in cases with red or blonde hair. Asp84glu variant alleles
were more common in subjects with blonde hair, though the relation-
ship between the asp84glu allele and hair color did not achieve statistical
significance (χ23 5 6.16, exact p 5 0.10). There was no difference in
the proportions of cases with red, blonde, brown, or black hair
demonstrating one or more copies of the val92met or asp294his alleles.
Table I also shows the frequencies of mutant alleles in the melanoma
cases grouped by tumor type and site. No significant associations
between MC1R alleles and histologic type of melanoma or tumor site
were identified.
Comparison of MC1R allele frequencies in melanoma cases and
controls Allele frequencies in the cases and controls were not
different when the uncorrected data were examined; however, after
correction for imbalances in age, gender, and skin type, the association
of the asp84glu allele with increased risk of melanoma approached
significance (p 5 0.069, odds ratio 5 3.0, 95% CI 5 0.9–9.6).
Inspection of the data shown in Table I shows that in cases with skin
types 3 and 4, the proportions of melanoma patients with the
val92met (25.4%) and asp84glu (10.0%) alleles was higher than in the
corresponding controls (13.7% and 2.8%, respectively).
DISCUSSION
Individual characteristics associated with pigmentation and sun sensitiv-
ity are determinants of susceptibility to melanoma (Kricker et al, 1993).
The recent association of skin type 1 and red hair with polymorphisms
in the MC1R gene (Valverde et al, 1995; Koppula et al, 1997) suggests
it is a susceptibility candidate for this cancer (Valverde et al, 1996).
Accordingly, we compared the frequencies of the two commonest
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variant alleles, asp294his and val92met, and the asp84glu variant in
controls and melanoma cases. We also examined the data for associations
between MC1R alleles and skin type, hair color, histologic type, and
tumor site. We have concentrated on these alleles because the remaining
alleles identified by Valverde et al (1995) demonstrated very low allele
frequencies (0.004–0.011). This would require an µ7-fold increase in
the allele frequency of the commonest of these (ala103val) before it
would reach statistical significance in this study. Though we cannot
exclude this as a possibility, it is less likely given the relatively small
odds ratios generally identified for the effects of single genes in case
control studies of multifactorial diseases such as melanoma. Although
the frequency of asp84glu is low in controls, we included analysis of
this allele as Valverde et al (1996) suggested that this allele was associated
with susceptibility to melanoma.
The controls comprised patients suffering benign cutaneous papil-
lomas. We selected dermatologic-based controls for two reasons: first,
they had been through a similar referral procedure and processing
through the clinics as the cases, and second, they had all been examined
by a trained dermatologist to exclude the presence of skin cancer.
The proportion of individuals with particular skin types and other
characteristics was similar to that described in previous studies from
this laboratory (Heagerty et al, 1996; Lear et al, 1996). Many studies
have shown the importance of skin type as a risk factor for cutaneous
cancers (Kricker et al, 1993; Katsambas and Nicolaidou, 1996). Skin
type is traditionally assessed using the Fitzpatrick scale (1988) that is
based on past reaction to UV exposure. Whereas classification into the
extreme types 1 and 4 appears straightforward, categorizing subjects
into types 2 and 3 is less reliable because it depends on patient
impression in often elderly subjects (Kricker et al, 1993). Hair color is
also an important risk marker. Thus, individuals with blonde or red
hair are at increased risk of melanoma (Katsambas and Nicolaidou,
1996); however, whereas these host factors are associated with risk, it
has not been possible to derive a single measure of host protective
capacity, partly because it is difficult to accurately determine parameters
such as hair color in earlier life when critical exposure events may
occur (Kricker et al, 1993).
The report by Valverde et al (1995), therefore, of a close relationship
in controls between MC1R alleles and skin types 1 and 2 and red hair
is important. Our data differ somewhat in several respects. First, we
found differences in the proportion of controls with the val92met and
asp294his alleles; 17.3% and 6.8% in our control subjects compared
with 9.6% and 16.3%, respectively, in the group (n 5 135) studied by
Valverde et al (1995). Second, whereas Valverde et al (1996) found no
asp84glu alleles in their 44 controls, we identified six of 168 controls
with this allele. The reason for these discrepancies is unclear, although
these frequencies are not statistically different. It may reflect population-
based differences in allele frequencies, although both studies are based
on English (or Irish in the case of Valverde et al, 1996) Caucasians, the
relatively small numbers of controls studied so far, or selection of
controls. A third difference concerns the strength of the relationship
between MC1R alleles and skin type. Valverde et al (1995) found a
strong association between the val92met and asp294his alleles and skin
type; no subjects with these alleles were found in the skin type 4
group. We did not find such a strong association. The frequency of
the val92met and asp84glu alleles was not significantly associated with
skin type, although generally the proportion of controls with at least
one copy of these alleles was lower in the skin 3 and 4 groups. Thus,
when all the controls with any one of the three alleles was studied,
trend analysis showed a significant inverse relationship between com-
bined allele frequency and skin type. Thus, although MC1R alleles
and skin type are associated, clearly other allelic variants or additional
genes must also contribute to skin phenotype. Fourth, the reported
association between hair color and MC1R alleles (Valverde et al, 1995)
was also not evident from our data. Whereas the number of controls
with red hair is relatively small (11 controls, 14 cases), it is noteworthy
that the frequency of variant alleles was not higher in subjects with
blonde or red compared with brown or black hair.
We did not find any significant differences in the frequency of
mutant alleles in controls and cases, indicating that, considered alone,
this gene does not appear a susceptibility candidate for melanoma,
though other allelic variants (possibly some yet unidentified) may be
important. Unexpectedly, we did not identify any association between
variant alleles and sun-sensitive skin types 1 and 2. Indeed, trend
analysis showed an association between sun-resistant skin type and the
proportion of melanoma cases with any one of the three alleles. These
data appear to indicate that at least some MC1R alleles influence
susceptibility to melanoma in subjects with skin types 3 and 4 but not
sun-sensitive types 1 and 2. The mechanism for this observation is
unknown, though Rees and Healy (1997) have argued that MC1R
alleles may be associated with MSH-dependent effects on melanocyte
growth rather than skin pigmentation. Indeed, accumulating evidence
indicates that MSH has wide ranging effects; these include inhibiting
production of various pro-inflammatory cytokines (e.g., TNF) and
prostaglandins (e.g., PGE2), and inhibition of contact sensitivity leading
to hapten-specific tolerance by inducing anti-inflammatory cytokines
such as IL-10 (Lipton and Catania, 1997).
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